90 related articles for article (PubMed ID: 3134719)
1. Comparison of HDR and LDR results in endometrium cancer.
Bekerus M; Durbaba M; Frim O; Vujnić V
Sonderb Strahlenther Onkol; 1988; 82():222-7. PubMed ID: 3134719
[No Abstract] [Full Text] [Related]
2. Five-year results and complications in endometrium cancer: HDR afterloading vs. conventional radium therapy.
Rauthe G; Vahrson H; Giers G
Sonderb Strahlenther Onkol; 1988; 82():240-5. PubMed ID: 3134721
[No Abstract] [Full Text] [Related]
3. Problems of HDR dose distribution in endometrium cancer: how to copy Heyman packing method?
Walstam R
Sonderb Strahlenther Onkol; 1988; 82():59-63. PubMed ID: 3134732
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation based on cost-effectiveness].
Inoue T; Inoue T
Gan To Kagaku Ryoho; 1998 Jan; 25(1):13-9. PubMed ID: 9464324
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy of cervical carcinoma using either HDR or LDR afterloading: comparison of 5-year results and complications.
Cikarić S
Sonderb Strahlenther Onkol; 1988; 82():119-22. PubMed ID: 3134706
[No Abstract] [Full Text] [Related]
6. Long-time results of HDR afterloading in comparison with radium therapy in endometrium cancer in Würzburg.
Rotte K
Sonderb Strahlenther Onkol; 1988; 82():218-21. PubMed ID: 3393992
[No Abstract] [Full Text] [Related]
7. Use of hysterosonography in the HDR afterloading treatment of endometrium cancer.
Hoetzinger H; Englmeier KH
Sonderb Strahlenther Onkol; 1988; 82():44-7. PubMed ID: 3134731
[No Abstract] [Full Text] [Related]
8. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
9. Experiences with HDR afterloading in endometrium cancer and results.
Kucera H
Sonderb Strahlenther Onkol; 1988; 82():228-36. PubMed ID: 3393993
[No Abstract] [Full Text] [Related]
10. Some aspects of afterloading therapy in endometrium cancer.
Ladner HA
Sonderb Strahlenther Onkol; 1988; 82():40-2. PubMed ID: 3134730
[No Abstract] [Full Text] [Related]
11. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
12. Control of applicator position by hysterography in HDR afterloading therapy of endometrium cancer.
Heine O; Roth G; Vahrson H
Sonderb Strahlenther Onkol; 1988; 82():254-5. PubMed ID: 3393997
[No Abstract] [Full Text] [Related]
13. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
[TBL] [Abstract][Full Text] [Related]
15. [Present and future in brachytherapy--from the discovery of radium to the 21st century].
Inoue T; Inoue T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1254-60. PubMed ID: 10478177
[TBL] [Abstract][Full Text] [Related]
16. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
[TBL] [Abstract][Full Text] [Related]
17. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
18. Problems and results of remote controlled afterloading therapy with high dose rate 252Cf in uterine cancer.
Yamashita H
Sonderb Strahlenther Onkol; 1988; 82():180-6. PubMed ID: 3393983
[No Abstract] [Full Text] [Related]
19. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience with a HDR device (Gammamed II-i) in the therapy of uterine neoplasms.
Vittori-Antisari P; Parisi S
Sonderb Strahlenther Onkol; 1988; 82():211-2. PubMed ID: 3393989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
